Art

J-GLOBAL ID：202102220357209115   Reference number：21A2788080

Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study

ヒト白血球抗原ハプロタイプ造血細胞移植後に注入されたドナー由来ナチュラルキラー細胞:用量漸増研究【JST・京大機械翻訳】

Author (19)： Choi Inpyo (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Yoon Suk Ran (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Park Soo-Yeon (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Kim Hanna (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Jung Sol-Ji (Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Jang Ye Jin (Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Kang Minho (Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Yeom Young Il (Medical Genomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea) ,  Lee Jae-Lyun (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Kim Dae-Young (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Lee Young-Shin (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Kang Young-Ah (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Jeon Mijin (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Seol Miee (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Lee Jung-Hee (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Lee Je-Hwan (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Kim Hwa Jung (Department of Clinical Epidemiology and Biostatistics, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Yun Sung-Cheol (Department of Clinical Epidemiology and Biostatistics, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea) ,  Lee Kyoo-Hyung (Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea)
Material： Biology of Blood and Marrow Transplantation  (Biol Blood Marrow Transplant)
Volume： 20  Issue： 5  Page： 696-704  Publication year： 2014 
JST Material Number： W1625A  ISSN： 1083-8791  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： The doses of donor-derived nat...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A2788080&from=J-GLOBAL&jstjournalNo=W1625A") }}

Thesaurus term： Mortality ,  Leukemia ,  haploid ,  *human leucocyte antigen ,  acute toxicity ,  *NK cell ,  *haplotype ,  GVH disease ,  acute leukemia ,  *hematopoietic stem cell transplantation ,  *donor ,  tolerability ,  Graft Survival ,  predictive factor ,  purine nucleoside ,  ribonucleoside

Author keywords (2)： Donor natural killer cell infusion ,  Human leukocyte antigen-haploidentical hematopoietic cell transplantation

JST classification (1)： Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (1)： Fludarabine

Terms in the title (9)： ヒト白血球抗原 ,  ハプロタイプ ,  造血細胞移植 ,  注入 ,  ドナー ,  ナチュラルキラー細胞 ,  用量 ,  漸増 ,  研究